Laura and Isaac Perlmutter Cancer Center — New York, New York

Laura and Isaac Perlmutter Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Laura and Isaac Perlmutter Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura and Isaac Perlmutter Cancer Center?

Laura and Isaac Perlmutter Cancer Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura and Isaac Perlmutter Cancer Center conducted?

Laura and Isaac Perlmutter Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis.

Is Laura and Isaac Perlmutter Cancer Center accredited by Crixeo Health?

Laura and Isaac Perlmutter Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Laura and Isaac Perlmutter Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.